Synthesis of pharmaceutically useful pyridine derivatives

Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

5462734, 5462737, 546290, 546303, 546310, 546312, 546345, C07D21361, C07D21362, C07D21372

Patent

active

06121454&

ABSTRACT:
A process is provided for the preparation of compounds of formula I, ##STR1## useful in the preparation of compounds such as Omeprazole, Lansoprazole and Pantoprazole, wherein R.sup.1 =H or CH.sub.3, R.sup.2 =H or CH.sub.3, R.sup.3 =Alkoxy (1-4C), OCH.sub.2 CF.sub.3, Cyano, Hydrogen, Halogen, Acetoxy or Aryloxy, any electron withdrawing group or salts (organic or inorganic) of electron donating groups, R=Alkoxy, Hydroxy, Halogen, Activated ester, Tosylate, Mesylate, Thiol or Xanthyl, wherein the process for the preparation of compound of formula I employs a free radical reaction to functionalize the 2-position.

REFERENCES:
patent: 3519717 (1970-07-01), Symchowicz et al.
patent: 4544750 (1985-10-01), Brandstrom et al.
patent: 4620008 (1986-10-01), Brandstom et al.
patent: 4672125 (1987-06-01), Gray et al.
patent: 5061805 (1991-10-01), Goe
patent: 5066810 (1991-11-01), Baumann
patent: 5374730 (1994-12-01), Slemon et al.
patent: 5386032 (1995-01-01), Brandstrom et al.
patent: 5510090 (1996-04-01), Cuillerdier et al.
Chou, S.Y., et al., "Synthesis of 2--Hydroxymethyl-3,5-Dimethyl-4-Methoxypyridine: A Key Intermediate for Omeprazole", Heterocylces, vol. 45, No. 1, 1997, pp. 77-85.
Kohl, B., et al., "AATPase Inhibiting 2-[(2-Pyridylmethyl)sulfinyl]benzimidazoles. 4..sup.1 A Novel Series of Dimethoxypyridyl-Substituted Inhibitors with Enhanced Selectivity. The Selection of Pantoprazole as a Clinical Candidate", J. Med. Chem. 1992, 35, pp. 1049-1057.
Crowe, A.M., et al., "The Preparation of .sup.14 C, .sup.35 S and .sup.13 C Labelled Forms of Omeprazole", Journal of Labelled Compounds and Radiopharmaceuticls, vol. XXIII, No. 1, pp. 21-33.
Weidmann, K., et al., 2-[(2-Pyridylmethyl)sulfinyl]-1H-thieno[3,4-d]imidazoles. A Novel Class of Gastric H+/K+-ATPase Inhibitors, J. Med. Chem., 1992, 35, 438-450.
Bernardi, R., et al., "Nucleophilic Character of Carbon Free Radicals. A New Convenient, Selective Carboxylation of Heteroaromatic Bases", Tetrahedron Letters No. 9, 1973, pp. 645-648.
Minisci, F., et al., "Recent Developments of Free-Radicals Substitutions of Heteroaromatic Bases", Heterocycles, vol. 28, No. 1, 1989, pp. 489-519.
Minisci, F., "Novel Applications of Free-Radicals Reactions in Preparative Organic Chemistry", Synthesis, Jan., 1973, pp. 1-24.
Minisci, "Novel Applications of Free-Radical Reactions in Preparative Organic Chemistry", Synthesis, No. 1, 1973, pp. 1-24.
Bernardi et al., "Nucleophilic character of carbon free radicals. A new convenient, selective carboxylation of heteroaromatic bases.", Tetrahedron Letters, vol. 9, 1973, pp. 645-648.
Fontana, et al., "Homolytic acylation of protonated pyridines and pyrazines with alpha-keto acids: the problem of monoacylation", J. Org. Chem., vol. 56, 1991, pp. 2866-2869.
Citterio, et al., "Nucleophilic character of the alkyl radicals. 19. Absolute rate constants in the homolytic alkylation of protonated heteroaromatic bases by n-butyl and tert.-butyl radicals.", J. Org. Chem., vol. 45, 1980, pp. 4752-4757.
Database WPI Section Ch, Week 9250 Derwent Publications Ltd., London, GB; AN 92-412945 & KR 9 109 817 B (Choong-Wae Pharm. Co.), 1991.
Chou, et al., "Synthesis of 2-hydroxymethyl-3,5-dimethyl-4-methoxypyridine: a key intermediate for omeprazole", Heterocycles, vol. 45, No. 1, 1997, pp. 77-85.
Database WPI Section Ch, Week 7406 Derwent Publications Ltd., London, GB; AN 74-10791V & SU 330 737 A (N-Caucasus Phytopath), 1974.
Chemical Abstracts, vol. 51, No. 12, Jun. 25, 1957, Columbus, Ohio, US; Jerchel, et al., "Synthesis with pyridylpyridium halides . . . ", col. 8737.
Epsztajn, et al., "Application of Organolithium and Related Reagents in Synthesis. Part 9.sup.1,. Synthesis and Metallation of 4-Chloropicolin- and 2-Chloroisonicotin-Anilides. A Useful Method for Preparation of 2,3,4-Trisubstituted Pyridines", Tetrahedron, vol. 47, No. 9, 1991, pp. 1697-1706.
Epsztajn, et al., "Application of Organolithium and Related Reagents in Synthesis Part 7.sup.1,. Synthesis and Metallation of 4-Methoxypicolin- and 2-Methoxyisonicotin-Anilides. A Useful Method for Preparation of 2,3,4-Trisubstituted Pyridines",Tetrahedron, vol. 45, No. 23, 1989, pp. 7469-7476.
Chu, et al., "Toward the Design for an RNA:DNA Hybrid Binding Agent", J. Am. Chem. Soc., vol. 116, 1994, pp. 2243-2253.
Godard, et al., "Synthesis of new substituted quinolizidines as potential inhibitors of ergosterol biosynthesis", Tetrahedron, vol. 51, No. 11, 1995, pp. 3247-3264.
Chemical Abstracts 121:35276, Kiselyov, Heterocycles, vol. 38(2), pp. 259-262, 1994.
Chemical Abstracts 120:322835, Huang, 1993.
chemical Abstracts 113:15227, Huang, 1990.
Chemical Abstracts 105:60499, Naumann, 1985.
Chemical Abstracts 127:190912, El-Bardan, 1997.
Chemical Abstracts 124:176004, Chbani, 1995.
Chemical Abstracts 124:105608, Lagorce, 1995.
Chemical Abstracts 111:7405, Lang, 1989.
Russell, chemical abstracts 111:133919, 1989.
Minisci, Chemical Abstracts 105:208247, 1986.
Russell, Chemical Abstracts 103:104823, 1985.
Minisci, Chemical Abstracts 70:28123, 1968.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Synthesis of pharmaceutically useful pyridine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Synthesis of pharmaceutically useful pyridine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Synthesis of pharmaceutically useful pyridine derivatives will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1074613

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.